Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: Comprehensive meta-analysis of all cancer sites.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 07 04 2020
revised: 16 11 2020
accepted: 20 12 2020
pubmed: 3 1 2021
medline: 16 2 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

Vitamin D receptors polymorphisms are found to be associated with several cancers. Since their prevalence vary across ethnicities and ethnicity itself seems to influence the cancer risk, a comprehensive meta-analysis was performed to investigate the role of VDR Fok1, Bsm1, Taq1, Apa1, Cdx2 and cancer risk at specific organ sites. Odds ratios, calculated with random-effects models, summarized one-hundred-ninety-two independent studies for twenty-two cancer sites. Evidence was provided that Fok1, Bsm1, Cdx2, Apa1 and Taq1 are linked to cancer susceptibility for colorectal, lung, ovarian, skin, multiple myeloma and brain cancer. Stratifying by ethnicity, some differences were found, partially explained by minor allele frequency (MAF), for colorectal cancer, ovarian and prostate cancer in Caucasian and prostate cancer in Asian populations. In summary, ethnicity may be a modifier of cancer risk, in particular for hormone dependent cancers and it should be considered evaluating the effect of VDR on cancer risk.

Identifiants

pubmed: 33387627
pii: S1040-8428(20)30338-3
doi: 10.1016/j.critrevonc.2020.103202
pii:
doi:

Substances chimiques

Receptors, Calcitriol 0
Vitamin D 1406-16-2

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103202

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Patrizia Gnagnarella (P)

Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: Patrizia.gnagnarella@ieo.it.

Sara Raimondi (S)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Valentina Aristarco (V)

Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.

Harriet Johansson (H)

Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.

Federica Bellerba (F)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Federica Corso (F)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Simone Pietro De Angelis (SP)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Pietro Belloni (P)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Statistical Sciences, University of Padua, Italy.

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Sara Gandini (S)

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH